InsightRP2: a Global Patient Registry for RP2-associated Retinitis Pigmentosa

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease and to support research in to a gene therapy for RP2-associated RP. We collect medical, genetic and imaging data from people affected by RP2-associated RP and will coduct a natural history study as well as image analysis studies.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• A molecular genetic diagnosis involving a heterozygous or hemizygous variant in RP2 and a written informed consent to participate are required for access to the registry questionnaire. Patients of all ages meeting the above criteria will be allowed to participate. As documentation will be in English and German, those who can navigate these pages will be included.

Locations
Other Locations
Germany
University Medicine Göttingen
RECRUITING
Göttingen
Contact Information
Primary
Nina Bögershausen, MD
insight.rp2@med.uni-goettingen.de
+49 (0)551 / 39-69016
Backup
Bernd Wollnik, MD, Prof.
insight.rp2@med.uni-goettingen.de
+49 (0)551 / 39-67589
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2045-05-01
Participants
Target number of participants: 200
Treatments
Individuals with Retinitis pigmentosa due to a variant / mutation in the RP2 gene
A molecular genetic diagnosis involving a heterozygous or hemizygous variant in RP2 and a written informed consent to participate are required for access to the registry questionnaire. Patients of all ages meeting the above criteria will be allowed to participate.
Sponsors
Leads: University of Göttingen

This content was sourced from clinicaltrials.gov